Patent Assignment
Reel/Frame 073972/0975
Assignment of Assignor's Interest
Recorded: 2026-03-04
Pages: 13
Assignor
TERWEY, THEIS
Executed: 2026-02-16
Assignee
GH RESEARCH IRELAND LIMITED
JOSHUA DAWSON HOUSE, DAWSON STREET, DUBLIN 2, DUBLIN, D02 RY95, IRELAND
Covered Properties
(28)
5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) for Treating Depression
Application:
17/431,626 →
Publication:
US 2022/0071958
5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) for Treating Depression
Application:
18/675,614 →
Compositions Comprising 5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) for Use in Treating Mental Disorders
Application:
17/431,634 →
Compositions Comprising 5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) for Use in Treating Mental Disorders
Application:
18/679,917 →
RECRYSTALLISATION OF 5-METHOXY-N,N-DIMETHYLTRYPTAMINE(5-MeO-DMT)
Aerosol Comprising 5-Methoxy-N,N-Dimethyltryptamine
Application:
17/801,389 →
Publication:
US 2023/0075124
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Bipolar Disorder
Application:
18/851,343 →
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Postpartum Depression
Application:
18/851,322 →
5-Meo-Dmt for the Treatment of Bipolar Disorder
Application:
18/851,336 →
5-Meo-Dmt for Use in the Treatment of Postpartum Depression
Application:
18/851,356 →
5-Meo-Dmt for Use in the Treatment of Sleep Disturbance
Application:
18/851,346 →
5-Meo-Dmt for Use in the Treatment of Sleep Disturbance
Application:
18/851,349 →
Treatment of Cognitive Dysfunction
Application:
18/850,376 →
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Cognitive Dysfunction
Application:
18/851,362 →
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Social/Emotional Withdrawal or Detachment
Application:
18/850,370 →
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Social/Emotional Withdrawal or Detachment
Application:
18/851,301 →
5-Meo-Dmt for Use in the Treatment of Negative Thinking
Application:
18/850,383 →
5-Meo-Dmt for Use in the Treatment of Negative Thinking
Application:
18/851,316 →
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Psychomotor Retardation
Application:
18/850,362 →
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Psychomotor Retardation
Application:
18/851,311 →
Treatment of Anxiety
Application:
18/850,348 →
5-Methoxy-N,N-Dimethyltryptamine for the Treatment of Anxiety
Application:
18/851,294 →
Treatment of Mental Disorders
Application:
18/850,394 →
Treatment of Postnatal Depression
Application:
18/851,329 →
Treatment of Mental Disorders
Application:
18/373,906 →
Treatment of Mental Disorders
Application:
18/373,904 →
Treatment of Mental Disorders
Application:
18/373,903 →
Treatment of Mental Disorders
Application:
18/373,914 →
Related Assignments
(2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 3, 2022
From: TERWAY, THEIS
To: GH RESEARCH IRELAND LIMITED
Reel/Frame 061288/0776 →
Assignment of Assignor's Interest
Mar 6, 2026
From: PATRICK, LEONARD GERARD FRANCIS, MR.; ROBINSON, SHAUN, MR.; STERLING PHARMA SOLUTIONS LIMITED
To: GH RESEARCH IRELAND LIMITED
Reel/Frame 073999/0349 →